Jul 22, 2017
Boots apologises for morning-after pill response
Boots has said it is "Truly sorry" for its response to calls to cut the cost of one of its morning-after pills. The progestogen-based drug Levonelle costs £28.25 in Boots, with a non-branded equivalent priced at £26.75. BPAS has lobbied Boots to reduce the cost of the pill to make it more accessible for women having difficulty getting the drug quickly on the NHS. The service also found the pills can cost up to five times more in the UK than in some parts of Europe. Previously, Boots had defended its pricing plan for the pill, saying it was often contacted by individuals who criticise the company for providing the service. The response led to some Labour MPs saying Boots had taken an "Unacceptable" moral position, while health campaigners talked of a "Sexist surcharge".
Related companies
Make a complaint about Boots by viewing their customer service contacts.
